This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Steiner, G. Search for Related Content Social Bookmarking                         What's this?

DAIS: how it relates to other lipid intervention studies in diabetes

Room NUW 9-107, Toronto General Hospital, 200 Elizabeth Street, Toronto, Ontario, Canada, M5G 2C4, george.steiner{at}utoronto.ca

The Diabetes Atherosclerosis Intervention Study (DAIS) was a multicentre, double-blind, randomised, placebo controlled, angiographic trial of the effects of fenofibrate on lipoprotein abnormalities in people with type 2 diabetes. Fenofibrate improved the lipid profile and retarded the progression of coronary artery disease. DAIS and its implications are considered within the context of other major lipid studies.

Key Words: fenofibrate • fibrates • statins • cholesterol • triglycerides • coronary artery disease • diabetes.

References

• Steiner G. Atherosclerosis, the major complication of diabetes. Adv Exp Med Biol 1985;189:277-97.[Web of Science][Medline] [Order article via Infotrieve]
• Anonymous. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease JAMA 1984; 251:351-64.[Abstract/Free Full Text]
• Anonymous. The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering JAMA 1984;251:365-74.[Abstract/Free Full Text]
• Steiner G. The Diabetes Atherosclerosis Intervention Study (DAIS): a study conducted in cooperation with the World Health Organisation. Diabetologia 1996;39:1655-61.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001;357:905-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McGuiness C., Seccombe DW, Frohlich JJ et al. Laboratory standardisation in a large international clinical trial: the DAIS experience. Clin Biochem 2000;33:15-24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• McLaughlin PR, Gladstone P. Diabetes Atherosclerosis Intervention Study (DAIS): quantitative coronary angiographic analysis of coronary artery atherosclerosis. Catheterization Cardiovasc Diagn 1998;44:249-56.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Vakkilainen J., Steiner G., Ansquer JC et al. DAIS Group. Relationships between low density lipoprotein particle size, plasma lipoproteins and progression of coronary artery disease. The Diabetes Atherosclerosis Intervention Study (DAIS) Circulation 2003;107:1733-7.
• Frick MH, Elo O., Haapa K. et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-45.[Abstract]
• Koskinen P., Manttari M., Manninen V., Huttunen JK, Heinonen OP, Frick MH Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study. Diabetes Care 1992;15:820-5.[Abstract]
• Downs JR, Clearfield M., Weis S. et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention. JAMA 1998;279:1615-22.[Abstract/Free Full Text]
• Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Pyorala K., Pedersen TR, Kjekshus J., Faergeman O., Olsson AG, Thorgeirsson G. Cholesterol lowering with simvastatin improves the prognosis of diabetic patients with coronary heart disease. Diabetes Care 1997;20:614-20.[Abstract]
• Goldberg RB, Mellies MJ, Sacks FM et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the Cholesterol and Recurrent Events (CARE) Trial. Circulation 1998;98: 2513-19.[Abstract/Free Full Text]
• The LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;76:474-9.
• Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Elkeles RS, Diamond JR, Poulter C. et al. the SENDCAP Study Group. Cardiovascular outcomes in type 2 diabetes: A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study Diabetes Care 1998;21:641-8.[Abstract]
• Rubins HB, Robins SJ, Collins D. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol: Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-18.[Abstract/Free Full Text]

The British Journal of Diabetes & Vascular Disease, Vol. 3, No. 3, 212-215 (2003)
DOI: 10.1177/14746514030030031001


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Steiner, G. Search for Related Content Social Bookmarking                         What's this?